Paper11706014
The 1.6-A crystal structure of the copper(II)-bound bleomycin complexed with the bleomycin-binding protein from bleomycin-producing Streptomyces verticillus.
Sugiyama M and 4 others. J Biol Chem, 2002. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. The 1.6-A crystal structure of the copper(II)-bound bleomycin complexed with the bleomycin-binding protein from bleomycin-producing Streptomyces verticillus. Papers, record 11706014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11706014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The 1.6-A crystal structure of the copper(II)-bound bleomycin complexed with the bleomycin-binding protein from bleomycin-producing Streptomyces verticillus.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetyltransferases | Major topic |
| Bacterial Proteins | Major topic |
| Bleomycin | Major topic |
| Copper | Major topic |
| Streptomyces | Major topic |
| Crystallography, X-Ray | |
| Culture Media | |
| Models, Molecular | |
| Molecular Structure | |
| Protein Binding |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37686404 | Interaction of Blenoxane and Congeners Bleomycins A2 and B2 with Human Plasma Proteins Using Circular Dichroism Spectroscopy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686404 | PubMed |
| 35184267 | Selectable Markers to Marker-Free Selection in Rice. | Mol Biotechnol | 2022 | https://conductscience.org/library/papers/35184267 | PubMed |
| 33912613 | Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy. | Inorganics (Basel) | 2018 | https://conductscience.org/library/papers/33912613 | PubMed |
| 29937405 | Resistance to Enediyne Antitumor Antibiotics by Sequestration. | Cell Chem Biol | 2018 | https://conductscience.org/library/papers/29937405 | PubMed |
| 28069656 | Characterization of BRPMBL, the Bleomycin Resistance Protein Associated with the Carbapenemase NDM. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28069656 | PubMed |
| 26512730 | Crystal Structure of the Zorbamycin-Binding Protein ZbmA, the Primary Self-Resistance Element in Streptomyces flavoviridis ATCC21892. | Biochemistry | 2015 | https://conductscience.org/library/papers/26512730 | PubMed |
| 25873321 | Structural biological study of self-resistance determinants in antibiotic-producing actinomycetes. | J Antibiot (Tokyo) | 2015 | https://conductscience.org/library/papers/25873321 | PubMed |
| 25299801 | BlmB and TlmB provide resistance to the bleomycin family of antitumor antibiotics by N-acetylating metal-free bleomycin, tallysomycin, phleomycin, and zorbamycin. | Biochemistry | 2014 | https://conductscience.org/library/papers/25299801 | PubMed |
| 24821625 | Biosynthetic modularity rules in the bisintercalator family of antitumor compounds. | Mar Drugs | 2014 | https://conductscience.org/library/papers/24821625 | PubMed |
| 23917114 | Contributions of NMR to the understanding of the coordination chemistry and DNA interactions of metallo-bleomycins. | Molecules | 2013 | https://conductscience.org/library/papers/23917114 | PubMed |
| 22481631 | Solution structure of Fe(II)-azide-bleomycin derived from NMR data: transition from Fe(II)-bleomycin to Fe(II)-azide-bleomycin as derived from NMR data and structural calculations. | J Biol Inorg Chem | 2012 | https://conductscience.org/library/papers/22481631 | PubMed |
| 20931575 | Weapons in disguise--activating mechanisms and protecting group chemistry in nature. | Chemistry | 2010 | https://conductscience.org/library/papers/20931575 | PubMed |
| 19889644 | Catalytic mechanism of bleomycin N-acetyltransferase proposed on the basis of its crystal structure. | J Biol Chem | 2010 | https://conductscience.org/library/papers/19889644 | PubMed |
| 18362349 | Crystal structure of DNA-bound Co(III) bleomycin B2: Insights on intercalation and minor groove binding. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18362349 | PubMed |
| 15578242 | The metal bonding domain of the antitumor drug Fe(II)-bleomycin: a DFT investigation. | J Biol Inorg Chem | 2005 | https://conductscience.org/library/papers/15578242 | PubMed |
| 15015041 | Structural study of copper(I)-bleomycin. | J Biol Inorg Chem | 2004 | https://conductscience.org/library/papers/15015041 | PubMed |
| 12632272 | The solution structure of the Ga(III)-bleomycin A2 complex resolved by NMR and molecular modeling; interaction with d(CCAGGCCTGG). | J Biol Inorg Chem | 2003 | https://conductscience.org/library/papers/12632272 | PubMed |
| 12433991 | Solution structure of the hydroperoxide of Co(III) phleomycin complexed with d(CCAGGCCTGG)2: evidence for binding by partial intercalation. | Nucleic Acids Res | 2002 | https://conductscience.org/library/papers/12433991 | PubMed |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11706014
GET https://conductscience.org/api/papers/v1/11706014/authors